Literature DB >> 1951128

Effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect.

T R Kimball1, S R Daniels, R A Meyer, D W Hannon, J Tian, R Shukla, D C Schwartz.   

Abstract

The effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect (VSD) is controversial. Nineteen infants with symptoms of congestive heart failure due to a VSD were studied with load-independent indexes during 4 study periods: (1) before any medication; (2) while on chronic diuretics; (3) while on both diuretics and digoxin; and (4) while on diuretics alone, to determine if digoxin: (a) increases "contractility" when added to diuretic therapy; and (b) improves symptoms. Symptoms, signs (heart and respiratory rates, and weight gain), shortening fraction, preload (left ventricular end-diastolic dimension), afterload (left ventricular end-systolic wall stress) and contractility were measured at each period. The difference between the measured and predicted velocities of circumferential fiber shortening for the measured left ventricular end-systolic wall stress served as an index of contractility. Eighteen infants also underwent catheterization. Mean pulmonary-to-systemic blood flow ratio was 3:1. When digoxin was added to diuretics, contractility index was significantly greater than in control subjects (0.13 +/- 0.15 vs 0.0 +/- 0.12 circ/s, p = 0.04). When patients were again on diuretics alone (after discontinuation of digoxin), contractility index was no longer different. Symptoms and signs were not significantly improved by either diuretics or digoxin. It is concluded that in infants with a large left-to-right VSD shunt and receiving digoxin and diuretics, contractility index was significantly greater than in control subjects. However, neither diuretics alone nor in combination with digoxin improved symptoms significantly.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1951128     DOI: 10.1016/0002-9149(91)90249-k

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Ventricular Septal Defect.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-12

2.  Atrioventricular Canal Defects.

Authors:  D J Murphy
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-12

Review 3.  Does digoxin still have a role in congestive heart failure?

Authors:  S S Kothari
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

Review 4.  Advances in understanding the physiological role and locations of carbonic anhydrases in C3 plant cells.

Authors:  Natalia N Rudenko; Lyudmila K Ignatova; Elena M Nadeeva-Zhurikova; Tatiana P Fedorchuk; Boris N Ivanov; Maria M Borisova-Mubarakshina
Journal:  Protoplasma       Date:  2020-10-28       Impact factor: 3.356

5.  Management of Chronic Congestive Heart Failure in Children.

Authors:  Ian Balfour
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

6.  Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts.

Authors:  Ozlem Elkiran; Ayse Sandikkaya; Gulendam Kocak; Cemsit Karakurt; Cagatay Taskapan; Saim Yologlu
Journal:  Pediatr Cardiol       Date:  2013-03-13       Impact factor: 1.655

7.  Digoxin in management of heart failure in children: Should it be continued or relegated to the history books?

Authors:  Shreepal Jain; Balu Vaidyanathan
Journal:  Ann Pediatr Cardiol       Date:  2009-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.